Investigational Drug Information for DSM265
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug DSM265?
DSM265 is an investigational drug.
There have been 7 clinical trials for DSM265.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Malaria, Malaria, Falciparum, and Malaria, Vivax. The leading clinical trial sponsors are Medicines for Malaria Venture, Q-Pharm Pty Limited, and AbbVie.
There are two US patents protecting this investigational drug and thirty-six international patents.
Summary for DSM265
| US Patents | 2 |
| International Patents | 36 |
| US Patent Applications | 14 |
| WIPO Patent Applications | 13 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-01-01) |
| Vendors | 21 |
Recent Clinical Trials for DSM265
| Title | Sponsor | Phase |
|---|---|---|
| Malaria: Relative Bioavailability and Food Effect of DSM265 | AbbVie | Phase 1 |
| Malaria: Relative Bioavailability and Food Effect of DSM265 | Medicines for Malaria Venture | Phase 1 |
| Bioavailability and Effect of Food on DSM265 Granules in Healthy Adult Subjects | AbbVie | Phase 1 |
Clinical Trial Summary for DSM265
Top disease conditions for DSM265
Top clinical trial sponsors for DSM265
US Patents for DSM265
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| DSM265 | See Plans and Pricing | Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, TX) MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH) UNIVERSITY OF WASHINGTON (Seattle, WA) | See Plans and Pricing |
| DSM265 | See Plans and Pricing | Substituted 2-alkyl-1-OXO-N-phenyl-3-heteroaryl-1,2,3,4-tetrahydroisoquinoline-4-carb- oxamides for antimalarial therapies | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (Memphis, TN) MMV MEDICINES FOR MALARIA VENTURE (Geneva, CH) RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (New Brunswick, NJ) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for DSM265
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| DSM265 | Brazil | BR112012007179 | 2029-09-29 | See Plans and Pricing |
| DSM265 | Canada | CA2775354 | 2029-09-29 | See Plans and Pricing |
| DSM265 | China | CN102741255 | 2029-09-29 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
